EGFR and lung carcinoma: The combination of genistein with other compounds is effective against non-small cell lung cancer (NSCLC) cell lines by targeting mutated EGFR, showing a synergistic anticancer effect; however, the exact role of genistein in lung cancer remains unclear [15].